Achmea Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,921
| Closed | -$2.45M | – | 367 |
|
|
2025
Q1 | $2.45M | Sell |
4,921
-1,984
| -29% | -$1.07M | 0.04% | 264 |
|
|
2024
Q4 | $3.59M | Sell |
6,905
-1,157
| -14% | -$636K | 0.06% | 243 |
|
|
2024
Q3 | $4.99M | Hold |
8,062
| – | – | 0.08% | 226 |
|
|
2024
Q2 | $4.46M | Hold |
8,062
| – | – | 0.08% | 233 |
|
|
2024
Q1 | $4.69M | Sell |
8,062
-8,135
| -50% | -$4.56M | 0.09% | 224 |
|
|
2023
Q4 | $8.6M | Hold |
16,197
| – | – | 0.18% | 144 |
|
|
2023
Q3 | $8.2M | Sell |
16,197
-8,646
| -35% | -$4.61M | 0.18% | 135 |
|
|
2023
Q2 | $13M | Buy |
24,843
+3,349
| +16% | +$1.81M | 0.27% | 89 |
|
|
2023
Q1 | $12.4M | Sell |
21,494
-1,393
| -6% | -$785K | 0.36% | 71 |
|
|
2022
Q4 | $11.8M | Sell |
22,887
-3,074
| -12% | -$1.63M | 0.4% | 58 |
|
|
2022
Q3 | $13.2M | Sell |
25,961
-3,264
| -11% | -$1.83M | 0.47% | 45 |
|
|
2022
Q2 | $15.9M | Sell |
29,225
-6,936
| -19% | -$3.82M | 0.51% | 36 |
|
|
2022
Q1 | $21.4M | Buy |
+36,161
| New | +$20.8M | 0.56% | 32 |
|
|
2021
Q4 | – | Sell |
-34,077
| Closed | -$19.5M | – | 575 |
|
|
2021
Q3 | $19.5M | Sell |
34,077
-584
| -2% | -$321K | 0.59% | 28 |
|
|
2021
Q2 | $17.5M | Sell |
34,661
-2,763
| -7% | -$1.3M | 0.6% | 31 |
|
|
2021
Q1 | $17.1M | Sell |
37,424
-3,814
| -9% | -$1.82M | 0.6% | 31 |
|
|
2020
Q4 | $19.2M | Buy |
41,238
+12,648
| +44% | +$5.93M | 0.69% | 25 |
|
|
2020
Q3 | $12.6M | Buy |
+28,590
| New | +$11.8M | 0.53% | 36 |
|
|
2020
Q1 | – | Sell |
-27,165
| Closed | -$8.83M | – | 526 |
|
|
2019
Q4 | $8.83M | Sell |
27,165
-699
| -3% | -$212K | 0.34% | 66 |
|
|
2019
Q3 | $8.12M | Sell |
27,864
-810
| -3% | -$232K | 0.32% | 72 |
|
|
2019
Q2 | $8.42M | Buy |
28,674
+97
| +0.3% | +$26.7K | 0.32% | 71 |
|
|
2019
Q1 | $7.82M | Buy |
28,577
+1,876
| +7% | +$467K | 0.33% | 69 |
|
|
2018
Q4 | $5.97M | Buy |
26,701
+6,301
| +31% | +$1.48M | 0.28% | 91 |
|
|
2018
Q3 | $4.98M | Sell |
20,400
-2,013
| -9% | -$463K | 0.19% | 125 |
|
|
2018
Q2 | $4.64M | Buy |
22,413
+4,954
| +28% | +$1.05M | 0.16% | 164 |
|
|
2018
Q1 | $3.6M | Buy |
17,459
+5,886
| +51% | +$1.24M | 0.12% | 195 |
|
|
2017
Q4 | $2.19M | Buy |
11,573
+1,816
| +19% | +$348K | 0.07% | 283 |
|
|
2017
Q3 | $1.84M | Sell |
9,757
-4,065
| -29% | -$736K | 0.1% | 250 |
|
|
2017
Q2 | $2.41M | Sell |
13,822
-2,839
| -17% | -$477K | 0.14% | 189 |
|
|
2017
Q1 | $2.56M | Buy |
+16,661
| New | +$2.55M | 0.12% | 220 |
|
Other funds holding TMO
Achmea Investment Management's TMO Position: Q2 2025 in Review
Achmea Investment Management sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 4,921 shares — an estimated $2.45M sold.
Achmea Investment Management first reported a position in TMO in Q1 2017 and held it in 30 quarters. The position peaked at $21.4M in Q1 2022. 2,453 funds tracked by Wall St. Rank hold TMO as of Q2 2025.
- Achmea Investment Management reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
- Achmea Investment Management sold 4,921 Thermo Fisher Scientific shares in Q2 2025, an estimated $2.45M.
- Achmea Investment Management first reported a position in Thermo Fisher Scientific in Q1 2017 and held it in 30 quarters.
- Achmea Investment Management's Thermo Fisher Scientific position peaked at $21.4M in Q1 2022.
- 2,453 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.
Based on Achmea Investment Management's 13F filing for Q2 2025, filed 6 Aug 2025.